2367 — Giant Biogene Holding Co Cashflow Statement
0.000.00%
- HK$31.40bn
- HK$21.86bn
- CNY5.52bn
Annual cashflow statement for Giant Biogene Holding Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 973 | 1,178 | 1,745 | 2,458 | 2,350 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -28.3 | 31.7 | -53.9 | -54.8 | -166 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -275 | -305 | -77.9 | -411 | -486 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 692 | 932 | 1,647 | 2,041 | 1,781 |
| Capital Expenditures | -111 | -153 | -228 | -247 | -429 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1,674 | -705 | -299 | -859 | 110 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1,563 | -859 | -527 | -1,106 | -319 |
| Financing Cash Flow Items | -2,619 | -379 | -3.54 | -7.97 | -11.3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4,476 | -5,790 | 51.8 | 583 | 918 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6,735 | -5,772 | 1,173 | 1,526 | 2,276 |